Error: Could not add to watchlist. X

Relmada Therapeutics Inc

+ Watchlist
0622463D:US
Ticker Change
0622463D:US has changed to a new ticker symbol
USD
Volume
0
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-
Market Cap (USD)
-
Shares Outstanding
-
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Specialty Pharma

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Relmada Therapeutics, Inc. is a clinical stage, public specialty pharmaceutical company who develops a variety of established drug products. The Company also researches and procures chemical entities with a focus on the treatment of pain.
ADDRESS
546 Fifth Avenue
14th Floor
New York, NY 10036
United States
PHONE
212-702-7163
  • Sergio Traversa
    Chief Executive Officer
  • Douglas Beck
    Chief Financial Officer
  • Christine Silverstein
    Dir:Investor Relations
Show More